Phenotyping Coronary Plaque by Computed Tomography in Premature Coronary Artery Disease.

Premature coronary artery disease coronary computed tomography angiography high-risk plaque non-calcified plaque

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
19 Aug 2023
Historique:
received: 10 05 2023
revised: 06 07 2023
accepted: 17 08 2023
medline: 19 8 2023
pubmed: 19 8 2023
entrez: 19 8 2023
Statut: aheadofprint

Résumé

Premature coronary artery disease (CAD) is an aggressive disease with multiple recurrences mostly related to new coronary lesions. This study aimed to compare coronary plaque characteristics of individuals with premature CAD with those of incidental plaques found in matched individuals free of overt cardiovascular disease, using coronary computed tomography angiography (CCTA). Of 1552 consecutive individuals who underwent CCTA, 106 individuals with history of acute or stable obstructive CAD ≤45 years were matched by age, sex, smoking status, cardiovascular heredity, and dyslipidemia with 106 controls. CCTA were analyzed for CAD-RADS score, plaque composition, and high-risk plaque features (HRP), including spotty calcification, positive remodeling, low-attenuation, and napkin-ring sign. The characteristics of 348 premature CAD plaques were compared with those of 167 incidental coronary plaques of matched controls. The prevalence of non-calcified plaques was higher among individuals with premature CAD (65.1% vs. 30.2%, p < 0.001), as well as spotty calcification (42.5% vs. 17.9%, p < 0.001), positive remodeling (41.5% vs. 9.4%, p < 0.001), low-attenuation (24.5% vs. 3.8%, p < 0.001) and napkin-ring sign (1.9% vs. 0.0%). They exhibited an average of 2.2[2.7] HRP, while the control group displayed 0.4[0.8] HRP (p < 0.001). Within a median follow-up of 24[16,34] months, individuals with premature CAD and ischemic recurrence (n = 24) had more HRP (4.3[3.9]) than those without ischemic recurrence (1.5[1.9]), mostly non-calcified with low-attenuation and positive remodeling. Coronary atherosclerosis in individuals with premature CAD is characterized by a high and predominant burden of non-calcified plaque and unusual high prevalence of HRP, contributing to disease progression with multiple recurrences. A comprehensive qualitative CCTA assessment of plaque characteristics may further risk stratify our patients, beyond cardiovascular risk factors.

Identifiants

pubmed: 37597177
pii: 7246361
doi: 10.1093/ehjci/jead212
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Ghilas Rahoual (G)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Michel Zeitouni (M)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Etienne Charpentier (E)

Sorbonne Université, INSERM UMRS 1146, CNRS, Institute of Cardiometabolism and Nutrition, unité d'Imagerie Cardiovasculaire et Thoracique, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Paul-Gydeon Ritvo (PG)

Sorbonne Université, INSERM UMRS 1146, CNRS, Institute of Cardiometabolism and Nutrition, unité d'Imagerie Cardiovasculaire et Thoracique, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Stéphanie Rouanet (S)

Statistician unit, StatEthic, ACTION Study group, Levallois-Perret, France.

Niki Procopi (N)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Sena Boukhelifa (S)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Pierre Charleux (P)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Paul Guedeney (P)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Mathieu Kerneis (M)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Olivier Barthélémy (O)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Johanne Silvain (J)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Gilles Montalescot (G)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Alban Redheuil (A)

Sorbonne Université, INSERM UMRS 1146, CNRS, Institute of Cardiometabolism and Nutrition, unité d'Imagerie Cardiovasculaire et Thoracique, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Jean-Philippe Collet (JP)

Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, 75013, France.

Classifications MeSH